Five-year follow-up of a multicenter phase II study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin (TEC) plus androgen-deprivation therapy (ADT) prior to radiation therapy in patients with unfavorable-risk localized prostate cancer: CALGB 99811
- Citation:
- Genitourinary Cancers Symposium abstr 123
- Meeting Instance:
- ASCO GU 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Long-Term-Followup
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 258
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- W. K. Kelly S. Halabi L. E. Archer J. A. Bogart M. J. Zelefsky E. J. Small
- Networks:
- Study
- CALGB-99811
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: